Cargando…

Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing

BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Matthew D., Podolsky, Robert H., Childers, Karen L., Higgins, Barbara, Trueman, Jillian, Homayouni, Ramin, Voss, Daniel R., Berkiw-Scenna, Natalie, Keil, Hans, Kennedy, Richard H., Maine, Gabriel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804961/
https://www.ncbi.nlm.nih.gov/pubmed/36596443
http://dx.doi.org/10.1016/j.jim.2022.113420
_version_ 1784862233192300544
author Sims, Matthew D.
Podolsky, Robert H.
Childers, Karen L.
Higgins, Barbara
Trueman, Jillian
Homayouni, Ramin
Voss, Daniel R.
Berkiw-Scenna, Natalie
Keil, Hans
Kennedy, Richard H.
Maine, Gabriel N.
author_facet Sims, Matthew D.
Podolsky, Robert H.
Childers, Karen L.
Higgins, Barbara
Trueman, Jillian
Homayouni, Ramin
Voss, Daniel R.
Berkiw-Scenna, Natalie
Keil, Hans
Kennedy, Richard H.
Maine, Gabriel N.
author_sort Sims, Matthew D.
collection PubMed
description BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immunoassays and semi-quantitative immunoassays performed in clinical laboratories, which typically require blood collected from a finger-stick and a standard venipuncture blood draw, respectively. This study evaluated the use of dried blood spot (DBS) collections as a sample source for COVID-19 antibody testing using an automated clinical laboratory test system. METHODS: Two hundred and ninety-four participants in the BLAST COVID-19 seroprevalence study (NCT04349202) were recruited at the time of a scheduled blood draw to have an additional sample taken via finger stick as a DBS collection. Using the EUROIMMUN assay to assess SARS-CoV-2 anti-spike IgG status, DBS specimens were tested on 7, 14, 21, and 28 days post- collection and compared to the reference serum sample obtained from a blood draw for the BLAST COVID-19 study. RESULTS: SARS-CoV-2 anti-spike IgG status from DBS collections demonstrated high concordance with serum across all time points (7–28 days). However, the semi-quantitative value from DBS collections was lower on average than that from serum, resulting in increased uncertainty around the equivocal-to-positive analytical decision point. CONCLUSIONS: DBS collections can be substituted for venipuncture when assaying for COVID-19 IgG antibody, with samples being stable for at least 28 days at room temperature. Finger-stick sampling can therefore be advantageous for testing large populations for SARS-CoV-2 antibodies without the need for phlebotomists or immediate processing of samples. We have high confidence in serostaus determination from DBS collections, although the reduced semi-quantitative value may cause some low-level positives to fall into the equivocal or even negative range.
format Online
Article
Text
id pubmed-9804961
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-98049612023-01-04 Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing Sims, Matthew D. Podolsky, Robert H. Childers, Karen L. Higgins, Barbara Trueman, Jillian Homayouni, Ramin Voss, Daniel R. Berkiw-Scenna, Natalie Keil, Hans Kennedy, Richard H. Maine, Gabriel N. J Immunol Methods Article BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immunoassays and semi-quantitative immunoassays performed in clinical laboratories, which typically require blood collected from a finger-stick and a standard venipuncture blood draw, respectively. This study evaluated the use of dried blood spot (DBS) collections as a sample source for COVID-19 antibody testing using an automated clinical laboratory test system. METHODS: Two hundred and ninety-four participants in the BLAST COVID-19 seroprevalence study (NCT04349202) were recruited at the time of a scheduled blood draw to have an additional sample taken via finger stick as a DBS collection. Using the EUROIMMUN assay to assess SARS-CoV-2 anti-spike IgG status, DBS specimens were tested on 7, 14, 21, and 28 days post- collection and compared to the reference serum sample obtained from a blood draw for the BLAST COVID-19 study. RESULTS: SARS-CoV-2 anti-spike IgG status from DBS collections demonstrated high concordance with serum across all time points (7–28 days). However, the semi-quantitative value from DBS collections was lower on average than that from serum, resulting in increased uncertainty around the equivocal-to-positive analytical decision point. CONCLUSIONS: DBS collections can be substituted for venipuncture when assaying for COVID-19 IgG antibody, with samples being stable for at least 28 days at room temperature. Finger-stick sampling can therefore be advantageous for testing large populations for SARS-CoV-2 antibodies without the need for phlebotomists or immediate processing of samples. We have high confidence in serostaus determination from DBS collections, although the reduced semi-quantitative value may cause some low-level positives to fall into the equivocal or even negative range. The Authors. Published by Elsevier B.V. 2023-02 2022-12-31 /pmc/articles/PMC9804961/ /pubmed/36596443 http://dx.doi.org/10.1016/j.jim.2022.113420 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sims, Matthew D.
Podolsky, Robert H.
Childers, Karen L.
Higgins, Barbara
Trueman, Jillian
Homayouni, Ramin
Voss, Daniel R.
Berkiw-Scenna, Natalie
Keil, Hans
Kennedy, Richard H.
Maine, Gabriel N.
Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title_full Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title_fullStr Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title_full_unstemmed Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title_short Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing
title_sort dried blood spots are a valid alternative to venipuncture for covid-19 antibody testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804961/
https://www.ncbi.nlm.nih.gov/pubmed/36596443
http://dx.doi.org/10.1016/j.jim.2022.113420
work_keys_str_mv AT simsmatthewd driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT podolskyroberth driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT childerskarenl driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT higginsbarbara driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT truemanjillian driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT homayouniramin driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT vossdanielr driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT berkiwscennanatalie driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT keilhans driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT kennedyrichardh driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting
AT mainegabrieln driedbloodspotsareavalidalternativetovenipunctureforcovid19antibodytesting